Arlington, VA 的 肥胖症 臨床試驗
18 項針對 肥胖症 的研究正在 Arlington（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
招募中2 期
- Washington Center For Weight Management And Research /ID# 282047, Arlington
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
招募中2 期
- Carient Heart and Vascular LLC-Reston, Reston · 距離 14 英里
- Carient Heart & Vascular - Manassas, Manassas · 距離 22 英里
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
招募中3 期
- Washington Cntr Weight Mgmt, Arlington
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Manassas · 距離 22 英里
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
招募中3 期
- Washington Cntr Weight Mgmt, Arlington
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
招募中3 期
- Research Site, Manassas · 距離 22 英里
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
招募中3 期
- Virginia Heart, Falls Church · 距離 4 英里
- Inova Cardiology - Fairfax, Fairfax · 距離 11 英里
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
招募中3 期
- Conquest Research, LLC, Arlington
- Virginia Heart, Falls Church · 距離 4 英里
- Carient Heart and Vascular, Manassas · 距離 22 英里
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
招募中3 期
- Manassas Clinical Research Center, Manassas · 距離 22 英里
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
招募中3 期歡迎健康志工
- ACCOMPLISH-2 Research Site, Burke · 距離 11 英里
- ACCOMPLISH-2 Research Site, Manassas · 距離 22 英里
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
招募中3 期
- Kailera Clinical Site, Manassas · 距離 22 英里
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
招募中3 期
- Washington Center for Weight Management and Research, Inc, Arlington
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
招募中3 期
- Manassas Clinical Research Center Inc, Manassas · 距離 22 英里
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
招募中3 期
- Kailera Clinical Site, Manassas · 距離 22 英里
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Arlington
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
招募中3 期
- Conquest Research, Vienna · 距離 9 英里
- Carient Heart and Vascular, Manassas · 距離 22 英里
Brief Inhibitory Training for Eating - Intervention
招募中
- George Mason University, Fairfax · 距離 11 英里
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
招募中3 期歡迎健康志工
- Vanda Investigational Site, Burke · 距離 11 英里
其他城市的 肥胖症 試驗
- Houston, TX43 項研究
- Chicago, IL41 項研究
- New York City, NY40 項研究
- San Antonio, TX40 項研究
- Washington, DC33 項研究
- Orlando, FL31 項研究
- Dallas, TX30 項研究
- Boston, MA28 項研究
- Las Vegas, NV27 項研究
- Miami, FL27 項研究
- Baltimore, MD25 項研究
- Jacksonville, FL25 項研究
Arlington 的其他研究
- 非小細胞肺癌104 項研究
- 轉移性癌症53 項研究
- 大腸直腸癌52 項研究
- 癌症（所有類型）48 項研究
- 乳癌46 項研究
- 卵巢癌46 項研究
- 肺癌41 項研究
- 子宮內膜癌39 項研究
- 胰臟癌33 項研究
- 頭頸部鱗狀細胞癌26 項研究
- 小細胞肺癌23 項研究
- 三陰性乳癌20 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。